AHA Coding Clinic® for HCPCS - 2021 Quarter 1; For Your Information
Discontinued HCPCS codes for drugs, biologicals and radiopharmaceuticals as of April 1, 2021
HCPCS Level II Code Long Descriptor Effective Date J7333 Hyaluronan or derivative, visco-3, for intra-articular injection, per dose March 31, 2021 J7401 Mometasone furoate sinus implant, 10 micrograms. April 1, 2021 ...
Subscribe or sign in to view the full article.
Article Overview
This short article summarizes a small HCPCS Level II update affecting discontinued drug, biological, and radiopharmaceutical coding as of April 1, 2021. It is useful for coders, billers, and revenue cycle staff who track code status changes and effective dates in outpatient and facility workflows.
Why This Topic Matters
Keeping current with HCPCS code status changes helps avoid use of outdated identifiers and supports accurate claims processing, chargemaster maintenance, and reference file updates.
What You Will Learn
- Which HCPCS Level II codes are listed in the update
- How the article presents effective dates for the discontinued codes
- What type of HCPCS code status information the notice provides
- How to recognize the scope of a short discontinued-code bulletin
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle teams
- Charge capture staff
- Compliance staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com